Skip to main content

EDITORIAL article

Front. Mol. Neurosci., 06 December 2022
Sec. Methods and Model Organisms
This article is part of the Research Topic Insights in Methods and Model Organisms: 2021 View all 9 articles

Editorial: Insights in methods and model organisms: 2021

  • Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland

Editorial on the Research Topic
Insights in methods and model organisms: 2021

For this Research Topic, we solicited forward-looking contributions on current and prospective use of methodology and models organisms in the field of molecular neuroscience. Indeed, we received a thought-provoking mix of review and original research articles that are briefly summarized in this editorial.

The review by Baratta et al. is written very much the same vein of this Research Topic in reporting on advances in genomic and behavioral analysis to understand normal and pathological brain function. Both approaches are the focus of intense research activities, taking advantage of both new instrumentation and increasingly more important data analysis tools. The complex and exciting relationship between genes and behavior necessitates such multipronged experimental approaches.

Enormous advances in imaging technology (including sample preparation and microcopy) and genetic engineering technologies have revolutionized the neurosciences. This is particularly apparent in the impressive number of studies published in the last few years using techniques that are ever more sophisticated to label specific cell types and their connections in the nervous system of mice. The review article by Arias et al. presents a much-needed guide to recent advances in the development of fluorescent transgenic mouse models with an eye to their use in understanding disease mechanisms.

Goel and Ploski discuss in their review the merits of short hairpin RNA-mediated (hRNA) gene silencing in light of the more recent gene editing tools provided by the CRISPR/Cas system. A particular concern is the chance of off-target effects of shRNA that may limit its utility in comparison to alternative CRISPR/Cas approaches.

In an original research article, Deng et al. describe a patient with a de novo non-sense mutation in the BRSK2 gene exhibiting characteristics of autism spectrum disorder (ASD). They went on to create a zebrafish mutant model using genome editing. BRSK2 deficient fish displayed neurodevelopmental deficits consistent with altered expression level of neurogenesis-related genes. Behaviorally these fish display impaired social preferences and shoaling behavior, establishing a new ASD animal model.

Alzheimer's disease (AD) is a recognized public health issue commanding a huge amount of research funding, predominantly using mice to model the disease. Yokoyama et al. discuss a variety of mouse models, including transgenic, knock-in, and injection based model, aiming to recapitulate aspects of the pathophysiological processes in AD. Other mouse models based on neuroinflammation and the involvement if microglia are also discussed.

Tello et al. address another approach to the study of AD in their review by reporting on recent advances on drug discovery using the fruit fly Drosophila melanogaster, a prominent invertebrate model for drug discovery. They argue that the most useful approach is to combine multiple screening methods such as morphological, behavioral and biomolecular analyses.

It is an important quest of diagnostic medical research to identify molecular biomarkers that are able to assist in diagnosis, patient stratification and prediction of disease outcome. Studies on the highly prevalent alcohol use disorder (AUD) are no exception. Ferguson et al. describe the latest research on using transcriptomic data and their analysis using artificial intelligence to identify molecular biomarker aiming at improving clinical management of AUD.

The reproducibility of any scientific experiment is one of the basic tenants of science. Ideally, any publication should provide all the information needed to repeat the describe experiments in any laboratory yielding comparable results. Much has been written about the current reproducibility crisis in Science with some of the discussions centering on the detailed description of experimental procedures. This is particularly true for behavioral experiments with its abundant ambient parameters affected outcome. Neuwirth et al. address the reporting of light conditions in their systematic review in publications on a number of standard behavioral neuroscience tests. They found that only a minority of reports state the exact lighting conditions under which the tests have been performed. The authors provide suggestions on how the behavioral neuroscience community should address this untenable situation helping efforts to booster validity of behavioral experiments.

Author contributions

The author confirms being the sole contributor of this work and has approved it for publication.

Conflict of interest

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: gene editing, neurobehavior tests, mouse, zebrafish, biomarker, Alzheimer's disease, autism spectrum disorder, alcohol use disorder

Citation: Neuhauss SCF (2022) Editorial: Insights in methods and model organisms: 2021. Front. Mol. Neurosci. 15:1104424. doi: 10.3389/fnmol.2022.1104424

Received: 21 November 2022; Accepted: 23 November 2022;
Published: 06 December 2022.

Edited and reviewed by: Jochen C. Meier, Technische Universitat Braunschweig, Germany

Copyright © 2022 Neuhauss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Stephan C. F. Neuhauss, stephan.neuhauss@uzh.ch

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.